ダウンロード数: 192

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
heartjnl-2016-311022.pdf1.6 MBAdobe PDF見る/開く
タイトル: Impact of the left ventricular mass index on the outcomes of severe aortic stenosis
著者: Minamino-Muta, Eri
Kato, Takao
Morimoto, Takeshi
Taniguchi, Tomohiko
Inoko, Moriaki
Haruna, Tetsuya
Izumi, Toshiaki
Miyamoto, Shoichi
Nakane, Eisaku
Sasaki, Kenichi
Funasako, Moritoshi
Ueyama, Koji
Shirai, Shinichi
Kitai, Takeshi
Izumi, Chisato
Nagao, Kazuya
Inada, Tsukasa
Tada, Eiji
Komasa, Akihiro
Ishii, Katsuhisa
Saito, Naritatsu  KAKEN_id  orcid https://orcid.org/0000-0001-9219-5279 (unconfirmed)
Sakata, Ryuzo
Minatoya, Kenji
Kimura, Takeshi  KAKEN_id
著者名の別形: 牟田, 恵里
加藤, 貴雄
齋藤, 成達
木村, 剛
発行日: Dec-2017
出版者: BMJ Publishing Group
誌名: Heart
巻: 103
号: 24
開始ページ: 1992
終了ページ: 1999
抄録: [Objective] To elucidate the factors associated with high left ventricular mass index (LVMI) and to test the hypothesis that high LVMI is associated with worse outcome in severe aortic stenosis (AS). [Methods] We analysed 3282 patients with LVMI data in a retrospective multicentre registry enrolling consecutive patients with severe AS in Japan. The management strategy, conservative or initial aortic valve replacement (AVR), was decided by the attending physician. High LVMI was defined as LVMI >115 g/m2 for males and >95 g/m2 for females. We compared the risk between normal and high LVMI in the primary outcome measures compromising aortic valve-related death and heart failure hospitalisation. [Results] Age was mean 77 (SD 9.6) years and peak aortic jet velocity (Vmax) was 4.1 (0.9) m/s. The factors associated with high LVMI (n=2374) included female, body mass index ≥22, absence of dyslipidemia, left ventricular ejection fraction <50%, Vmax ≥4 m/s, regurgitant valvular disease, hypertension, anaemia and end-stage renal disease. In the conservative management cohort (normal LVMI: n=691, high LVMI: n=1480), the excess adjusted 5-year risk of high LVMI was significant (HR: 1.53, 95% CI 1.26 to 1.85, p<0.001). In the initial AVR cohort (normal LVMI: n=217, high LVMI: n=894), the risk did not differ significantly between the two groups (HR: 0.96, 95% CI 0.60 to 1.55, p=0.88). There was a significant interaction between the initial treatment strategy and the risk of high LVMI (p=0.016). [Conclusions] The deleterious impact of high LVMI on outcome was observed in patients managed conservatively, but not observed in patients managed with initial AVR. [Trial registration number] UMIN000012140; Post-results.
著作権等: © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
URI: http://hdl.handle.net/2433/227790
DOI(出版社版): 10.1136/heartjnl-2016-311022
PubMed ID: 28684442
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。